Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Solvay Pharmaceuticals | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Safety and tolerability of single oral doses in healthy subjects.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | 0.5 mg SLV-351 (fasted) |
|
| 2 | Experimental | 1 mg SLV-351 (fasted) |
|
| 3 | Experimental | 2.5 mg SLV-351 (fasted) |
|
| 4 | Experimental | 5 mg SLV-351 (fasted) |
|
| 5 | Experimental | 10 mg SLV-351 (fasted) |
|
| 6 | Experimental | 15 mg SLV-351 (fasted) |
|
| 7 | Experimental |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SLV-351 | Drug | SLV-351 capsules taken once |
|
| Measure | Description | Time Frame |
|---|---|---|
| Safet and tolerability | 35 days |
| Measure | Description | Time Frame |
|---|---|---|
| PK and PD | 35 days |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Monitor | Wyeth is now a wholly owned subsidiary of Pfizer | Study Director |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
20 mg SLV-351 (fasted)
|
| 8 | Experimental | 30 mg SLV-351 (fasted) |
|
| 9 | Experimental | xx mg SLV-351 (fasted and fed) |
|